Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

BACKGROUND: The purpose of this study was to explore the budget impact of dutasteride plus tamsulosin fixed-dose combination (DUT + TAM FDC) versus tamsulosin monotherapy, in the treatment of patients with benign prostatic hyperplasia (BPH) from the perspective of the Greek healthcare insurance syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Geitona, Maria, Karabela, Pinelopi, Katsoulis, Ioannis A, Kousoulakou, Hara, Lyberopoulou, Eleni, Bitros, Eleftherios, Xaplanteris, Loukas, Papanicolaou, Sotiria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236714/
https://www.ncbi.nlm.nih.gov/pubmed/25255740
http://dx.doi.org/10.1186/1471-2490-14-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236714/
https://www.ncbi.nlm.nih.gov/pubmed/25255740
http://dx.doi.org/10.1186/1471-2490-14-78

Ejemplares similares